Paul Tudor Jones Vericel Corp Transaction History

Tudor Investment Corp Et Al

  • $26.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023
SELL
$31.69 - $39.25 $160,699 - $199,036
-5,071 Reduced 22.86%
17,111 $573,000
Q2 2023

Aug 14, 2023
BUY
$29.0 - $38.37 $224,141 - $296,561
7,729 Added 53.48%
22,182 $833,000
Q1 2023

May 15, 2023
BUY
$23.85 - $31.34 $344,704 - $452,957
14,453 New
14,453 $424,000
Q2 2022

Aug 15, 2022
SELL
$22.88 - $39.45 $13,911 - $23,985
-608 Reduced 3.69%
15,858 $399,000
Q1 2022

May 16, 2022
BUY
$31.69 - $43.29 $521,807 - $712,813
16,466 New
16,466 $629,000

Others Institutions Holding VCEL

# of Institutions
276
Shares Held
48.5M
Call Options Held
91.8K
Put Options Held
23.2K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email